Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026)
Incannex Healthcare (IXHL) posted Depreciation & Amortization (CF) of $65000.0 for Q1 2026, up 10.17% sequentially from $59000.0 in Q4 2025, and up 1400.0% YoY from $4333.3 in Q1 2025.
Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $65000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 1400.0% year-over-year to $65000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $251000.0 (up 1.62% YoY) and the FY2025 annual result came in at $246000.0, up 138.83% from the prior year.
- Depreciation & Amortization (CF) grew to $65000.0 in Q1 2026 per IXHL's latest filing, from $59000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $126000.0 in Q4 2024 and troughed at -$13000.0 in Q1 2023.
- A 4-year average of $45538.5 and a median of $61000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) slumped 129.41% in 2025, then jumped 1400.0% in 2026.
- Over 4 years, Depreciation & Amortization (CF) stood at $12000.0 in 2023, then jumped by 950.0% to $126000.0 in 2024, then tumbled by 53.17% to $59000.0 in 2025, then climbed by 10.17% to $65000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $65000.0, $59000.0, and $66000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |